Treatment

Quantitative neuromuscular MRI clinical trials

2 indexed studies · 2 currently recruiting

RecruitingNA
Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease
This study looks for new ways to measure Charcot-Marie-Tooth disease type 1A (CMT1A) early on. It involves 35 people with CMT1A and 20 healthy volunteers, aged 10-30, over two years. The goal is to find markers that predict how the disease might progress.
For: Charcot-Marie-Tooth Disease Type 1A
France
RecruitingNA
Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients
This study uses special MRI scans to look at muscle changes in people with certain nerve conditions like Charcot-Marie-Tooth. It aims to see if these scans can better track how the conditions progress and if treatments are working.
For: Charcot-Marie-Tooth Neuropathy Type 1A · Hereditary Transthyretin Amyloid Neuropathy · Acquired Demyelinating Neuropathy
France